Search

everythinglearnresearchcommunity

for

Search:↓

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Some drugs can cause changes to your hair.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Polymeric nanoparticles could improve hair loss treatments by delivering drugs more effectively to hair follicles.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Provenge extends prostate cancer survival by about 4 months.

Certain drugs can change hair color, either lightening or darkening it.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Indian herbal medicine shows promise for treating skin diseases but needs more research to prove effectiveness.

Melatonin helps reduce aging signs in human eyelid skin.

High mTORC1 activity slows hair growth and causes it to lose color.